Evotec AG CFO Unloads $40,800 in Stock (EVTC)
Evotec AG (NASDAQ:EVTC) CFO Jimenez Juan Jose Roman unloaded 1,700 shares of Evotec AG stock on the open market in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $24.00, for a total transaction of $40,800.00. Following the completion of the sale, the chief financial officer now directly owns 244,053 shares of the company’s stock, valued at approximately $5,857,272. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of Evotec AG (NASDAQ:EVTC) traded up 0.13% on Friday, hitting $23.93. 221,081 shares of the company’s stock traded hands. Evotec AG has a 1-year low of $19.50 and a 1-year high of $26.33. The stock’s 50-day moving average is $23.38 and its 200-day moving average is $23.82. The company’s market cap is $1.875 billion.
Evotec AG (NASDAQ:EVTC) last released its earnings data on Wednesday, May 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. The company had revenue of $87.20 million for the quarter, compared to the consensus estimate of $91.26 million. The company’s revenue for the quarter was down .1% on a year-over-year basis. Analysts expect that Evotec AG will post $1.68 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, June 6th. Stockholders of record on Monday, May 19th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date of this dividend is Thursday, May 15th.
Evotec AG is a Germany-based parent company of the Evotec group, which is engaged in drug discovery and development company focused on providing integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.